ABVC BioPharma, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ABVC BioPharma, Inc. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $383.50K, a 172.47% increase year-over-year.
- ABVC BioPharma, Inc. stock issued during period, value, issued for services for the quarter ending 2023-09-30 was $592.00K, a 133.53% increase year-over-year.
- ABVC BioPharma, Inc. stock issued during period, value, issued for services for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- ABVC BioPharma, Inc. stock issued during period, value, issued for services for the quarter ending 2023-03-31 was $140.75K, a 96.85% decline year-over-year.
- ABVC BioPharma, Inc. stock issued during period, value, issued for services for fiscal 2023 was $196.10K, a 95.99% decline from fiscal 2022.
- ABVC BioPharma, Inc. stock issued during period, value, issued for services for fiscal 2022 was $4.89M, a 183.00% increase from fiscal 2021.
- ABVC BioPharma, Inc. stock issued during period, value, issued for services for fiscal 2021 was $1.73M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2024-03-31 | $383.50K 10-Q · filed 2024-05-17 | |
| 2023-12-31 | $196.10K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $592.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | |
| 2023-03-31 | $140.75K 10-Q · filed 2024-05-17 | |
| 2022-12-31 | $4.89M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $253.50K 10-Q · filed 2023-11-15 | |
| 2022-06-30 | $3.66M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $4.47M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $1.73M 10-K · filed 2023-03-31 | |
| 2021-06-30 | $250.00K 10-Q · filed 2022-11-14 |